Skip to main content
    AngelBacked

    Maze Therapeutics

    BiopharmaSouth San Francisco, California, United StatesPost-IPO Equity$796.0M total fundingwww.mazetx.com
    Latest funding:$150.0M · Post-IPO Equity (April 22, 2026)

    Angel investors who backed Maze Therapeutics

    32 investors in our database backed Maze Therapeutics.

    Eli Casdin

    Chief Investment Officer

    Steve Gillis

    Managing Director

    Keith Crandell

    Co-Founder and Managing Director

    Luke Bagaason, CFA

    Manager - Portfolio Valuation

    Dennis Ryan

    Chief Financial Officer & Managing Director

    Dorothy Margolskee

    Managing Director

    Richard Lau, CFA

    Partner

    Sean Kendall

    Partner

    Nilay Thakar

    Principal

    Tom Brennan

    Venture Partner

    Carol Suh

    Partner

    Corey Ritter

    Partner

    Clinton Bybee

    Co-Founder and Managing Director

    Mark McDonnell

    CFO, CAO and Managing Director

    Ari Nowacek

    Principal

    Jeffrey Tong

    Partner

    Abbie Celniker

    Partner

    Neil Exter

    Partner

    Craig Muir

    Partner and CTO

    Cary Pfeffer

    Partner

    Mark Levin

    partner

    Walter Kowtoniuk

    Venture Partner

    Philip Reilly

    venture partner

    Josephine Kahn

    Senior Associate / Consultant

    George Xu

    Director, Corporate Strategy and Portfolio Development

    Noreen Rizvi

    Principal

    Reid Huber

    Partner

    Christoph Lengauer

    Adjunct Associate Professor

    Andrew Warren

    Senior Director, CSO Partner Team

    Robert Tepper

    Partner

    William Motley

    Senior Associate

    Jonathan Lim

    Venture Partner

    View the full investor list for Maze Therapeutics

    Find the right investors for your startup

    Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Maze Therapeutics.

    Search investors